PVLA
Palvella Therapeutics, Inc.$144.50-7.97 (-5.23%)Prev Close$152.48·MCap$2.47B·P/E—·Vol213.5K·Yield—
▲
Buys (12M)
3
$850.0K
▼
Sells (12M)
17
$16.26M
◆
Net Activity
Net Seller
$15.41M
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at Palvella Therapeutics, Inc. (PVLA) has been dominated by selling, with 3 insider purchases totaling $850.0K and 17 insider sales totaling $16.26M. The most recent insider transaction was by Martini Jeffrey S (officer: Chief Scientific Officer), who sold $2.08M worth of shares on Nov 12, 2026. Palvella Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.47B.
PVLA Insider Trading Activity
PVLA Insider Buying Activity
The following table shows recent insider purchases of Palvella Therapeutics, Inc. (PVLA) stock reported via SEC Form 4 filings.
PVLA Insider Selling Activity
The following table shows recent insider sales of Palvella Therapeutics, Inc. (PVLA) stock reported via SEC Form 4 filings.